Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer

Conventional chemotherapy of ovarian cancer often fails because of initiation of drug resistance and/or side effects and trace of untouched remaining cancerous cells. This highlights an urgent need for advanced targeted therapies for effective remediation of the disease using a cytotoxic agent with...

Descripción completa

Detalles Bibliográficos
Autores principales: Matthaiou, Efthymia-Iliana, Barar, Jaleh, Sandaltzopoulos, Raphael, Li, Chunsheng, Coukos, George, Omidi, Yadollah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998853/
https://www.ncbi.nlm.nih.gov/pubmed/24790428
http://dx.doi.org/10.2147/IJN.S51880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998853/
https://www.ncbi.nlm.nih.gov/pubmed/24790428
http://dx.doi.org/10.2147/IJN.S51880

Ejemplares similares